Currently out of the existing stock ratings of Shaunak Deepak, 9 are a BUY (100%).

Shaunak Deepak

Work Performance Price Targets & Ratings Chart

Analyst Shaunak Deepak, carries an average stock price target met ratio of 33.33% that have a potential upside of 21.26% achieved within 149 days. Previously, Shaunak Deepak worked at HC WAINWRIGHT, JEFFERIES, AVONDALE.

Shaunak Deepak’s has documented 15 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on KPTI, Karyopharm Therapeutics at 17-Mar-2017.

Wall Street Analyst Shaunak Deepak

Analyst best performing recommendations are on KPTI (KARYOPHARM THERAPEUTICS).
The best stock recommendation documented was for KPTI (KARYOPHARM THERAPEUTICS) at 8/18/2016. The price target of $225 was fulfilled within 560 days with a profit of $108.15 (92.55%) receiving and performance score of 1.65.

Average potential price target upside

MNKD MannKind Corp KPTI Karyopharm Therapeutics RIGL Rigel Pharmaceuticals SYBX Synlogic DRNA Dicerna Pharmaceuticals LXRX Lexicon Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 25-Oct-2019

$10

$5.86 (141.55%)

$8

2 months 21 days ago
(07-May-2026)

5/14 (35.71%)

$6.45 (181.69%)

760

Buy Since 27-Feb-2026

$10

$5.86 (141.55%)

$8

2 months 21 days ago
(07-May-2026)

0/4 (0%)

$6.45 (181.69%)

Buy Since 10-Apr-2025

$7

$2.86 (69.08%)

$8

2 months 21 days ago
(07-May-2026)

0/4 (0%)

$3.45 (97.18%)

Hold Since 07-May-2026

$4.75

$0.61 (14.73%)

$3.5

2 months 21 days ago
(07-May-2026)

1/6 (16.67%)

$1.2 (33.80%)

68

Buy Since 09-Dec-2025

$9

$4.86 (117.39%)

7 months 19 days ago
(09-Dec-2025)

0/1 (0%)

$3.23 (55.98%)

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Shaunak Deepak?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?